#Canada #Laval, QC #Bausch Health #Clear + Brilliant #Solta Medical

Bausch Health's Solta Medical Launches Clear + Brilliant® Touch Laser in Canada

In a significant move for the aesthetics industry, Bausch Health Companies Inc. has announced the launch of the Clear + Brilliant® Touch laser through its subsidiary, Solta Medical. This innovative device has garnered Health Canada’s approval as of May 20, 2025, marking a pivotal moment in non-invasive skin rejuvenation treatments across the Canadian market. With the growing demand for effective and safe skin treatments, the introduction of this advanced technology is expected to meet the needs of both patients and healthcare providers.

A Revolutionary Technology

The Clear + Brilliant® Touch system is renowned for its dual-wavelength laser technology, which enables customizable treatments suited for various skin types and concerns. This system offers Canadian physicians an opportunity to provide personalized solutions to their patients, aligning with the increasing trend toward effective yet approachable skincare options. Thomas J. Appio, CEO of Bausch Health, emphasized, "The Solta business continues to expand its global presence through its diverse and well-established portfolio that supports the growing demand for high-quality aesthetics solutions."

The device is not only designed for versatility across a demographic of patients, but it is also suitable for year-round use dependent on the physician's discretion. Its innovative design promotes ease of use while minimizing downtime, making it an attractive choice for busy individuals seeking skin treatments with gentle yet effective results.

Clear + Brilliant® Touch Laser Features

The Clear + Brilliant® Touch System comprises two distinct fractional laser handpieces:

• - 1440 nm Handpiece: Targets wrinkles, dyschromia, pigmentation, skin texture, and pore size improvement.
• - 1927 nm Handpiece: Focuses on enhancing skin permeability and also addresses similar issues of pigmentation and texture.

These features enable a thorough approach to skin rejuvenation, helping patients achieve smoother, youthful-looking skin. Additionally, with over 15 clinical studies backing its efficacy, the Clear + Brilliant® platform has set a benchmark in the global laser-treatment landscape.

Commitment to Skin Health

Jiny Kim, Senior Vice President at Solta Medical, expressed the importance of this launch for the company, stating, "Expanding the availability of the Clear + Brilliant Touch System into Canada marks a significant step forward for Solta Medical and its commitment to global expansion of our innovative portfolio of products in skin health." This highlights Solta's dedication to providing cutting-edge technology that meets the evolving needs of healthcare providers and patients alike.

As Canadians increasingly seek solutions for early signs of aging and skin maintenance, the Clear + Brilliant® Touch laser promises to fulfill this demand while further establishing Bausch Health and Solta Medical as leaders in the aesthetic market.

About Solta Medical and Bausch Health

Bausch Health Companies Inc. operates as a diversified pharmaceutical company with a commitment to enhancing health care outcomes. With a focus on various medical fields, including dermatology and aesthetics, their Solta Medical subsidiary stands as a global leader in providing effective skin health solutions. For more information about their offerings, visit Bausch Health or Solta Medical. This commitment not only addresses current market demands but also ensures patient safety and effectiveness in all treatments provided.

In conclusion, the Clear + Brilliant® Touch laser launch in Canada is set to revolutionize the country's aesthetic practices, marking a new chapter in the pursuit of safe, innovative skin rejuvenation options. Physicians and patients alike can look forward to enhanced skin health with this groundbreaking technology.